 |
|
|
Imodium Capsules (pack of 8) |
|
Loperamide hydrochloride 2 mg
Excipient: lactose
Capsule, hard.
Opaque green cap and grey body, hard gelatin capsule imprinted with 'Imodium' on cap and 'Janssen' on body containing white powder
For the symptomatic treatment of acute diarrhoea in adults and children aged 12 years and over.
For the symptomatic treatment of acute episodes of diarrhoea associated with Irritable Bowel Syndrome in adults aged 18 years and over following initial diagnosis by a doctor.
|
|
Adults and children over 12:
Two capsules initially, followed by one capsule after each loose stool. The usual dose is 3-4 capsules a day. The total daily dose should not exceed 8 capsules.
|
|
USE IN ELDERLY
No dose adjustment is required for the elderly.
RENAL IMPAIRMENT
No dose adjustment is required for patients with renal impairment.
HEPATIC IMPAIRMENT
Although no pharmacokinetic data are available in patients with hepatic impairment, Imodium should be used with caution in such patients because of reduced first pass metabolism (see 4.4 Special warnings and precautions for use).
Method of administration
Oral use.
Imodium is contraindicated in:
• patients with a known hypersensitivity to loperamide hydrochloride or to any of the excipients.
• children less than 4 years of age.
• when inhibition of peristalsis is to be avoided due to the possible risk of significant sequelae including ileus, megacolon and toxic megacolon, in particular:
- when ileus or constipation are present or when abdominal distension develops, particularly in severely dehydrated children,
- in patients with acute ulcerative colitis,
- in patients with bacterial enterocolitis caused by invasive organisms including Salmonella, Shigella, and Campylobacter,
- in patients with pseudomembranous colitis associated with the use of broad-spectrum antibiotics.
Imodium should not be used alone in acute dysentery, which is characterised by blood in stools and elevated body temperatures.
|
|
|
